Amvuttra (vutrisiran) is a prescription medication that's used to treat nerve damage in people with a rare condition called hereditary transthyretin-mediated amyloidosis (hATTR). It's injected under the skin once every 3 months by a healthcare provider, typically at their office. Some common side effects caused by Amvuttra (vutrisiran) include joint pain and trouble breathing.
Polyneuropathy (nerve damage) from hereditary ATTR (hATTR) amyloidosis
Amvuttra (vutrisiran) is a type of medication called small interfering ribonucleic acid (siRNA). It's used to treat polyneuropathy (nerve damage) in people with hATTR amyloidosis.
Your liver makes a protein called transthyretin (TTR) that plays important roles in your body. If you have hATTR amyloidosis, you have a mutation (change) in the gene that makes this protein. This change causes your liver to make TTR proteins that clump together in clusters called amyloid deposits. The deposits can build up in different parts of your body and cause damage to your organs and nerves.
Amvuttra (vutrisiran) eases some symptoms of hATTR amyloidosis by interrupting the TTR gene so that it produces less TTR proteins, thus less amyloid deposits.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Injected once every 3 months
Injected under the skin, instead of through the veins
Doesn't require pre-treatment medications, so might be more convenient compared to Onpattro (patisiran)
Not many interactions with other medications
Only available as a brand medication so it might be expensive
Likely to cause low vitamin A levels
Needs to be given by a healthcare provider
Unknown if safe or works well in children
It's best to get your Amvuttra (vutrisiran) injection once every 3 months. Consider marking your appointments with your provider on your calendar. If you miss a treatment, talk with your provider right away about rescheduling your appointment.
Amvuttra (vutrisiran) can lower the amount of vitamin A in your blood. As a result, your provider might ask you to take a vitamin A supplement every day. Let your provider know if you have any vision changes, such as night blindness, dry eyes, spots in your eyes, or cloudy corneas. These can be signs and symptoms of too little vitamin A in your blood.
Don't take more vitamin A than what's recommended by your provider. Too much vitamin A can cause symptoms such as severe headache, nausea, dizziness, and muscle aches.
Amvuttra (vutrisiran) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Amvuttra (vutrisiran) can cause the vitamin A level in your blood to drop. This can lead to problems such as poor night vision and raise your risk for infections. Your provider might ask you to take a vitamin A supplement while you're being treated with this medication. But don't take more vitamin A than directed by your provider because doing so can cause severe headache, nausea, dizziness, and muscle aches. Let your provider know if you're experiencing blurry vision or trouble seeing at night, which are common symptoms of low vitamin A levels.
The typical dose for Amvuttra (vutrisiran) is 25 mg injected under the skin by a healthcare provider once every 3 months.
Polyneuropathy (nerve damage) from hereditary ATTR (hATTR) amyloidosis
Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)
Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.